![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Salama April K. S. Rosa Nicole de Scheri Randall P. Herndon James E. Tyler Douglas S. Marcello Jennifer Pruitt Scott K. Abernethy Amy P.
Publisher: Informa Healthcare
ISSN: 0735-7907
Source: Cancer Investigation, Vol.30, Iss.9, 2012-10, pp. : 637-641
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metastatic melanoma: Is biochemotherapy the future?
By Alexandrescu Doru Dutcher Janice Wrnik Peter
Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Malignant Melanoma Metastatic to the Ovary
By Piura B. Kedar I. Ariad S. Meirovitz M. Yanai-Inbar I.
Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oblimersen in the treatment of metastatic melanoma
By Tarhini Ahmad A Kirkwood John M
Future Oncology, Vol. 3, Iss. 3, 2007-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A New Allogeneic Model for Metastatic Melanoma
European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. :